Amgen announces results from three studies in the safety and efficacy of Nplate Amgen Inc.

Amgen announces results from three studies in the safety and efficacy of Nplate Amgen Inc online pharmacy . MDS is usually a pre-leukemic condition in which early bloodstream forming cells in the bone marrow are unable to mature normally, limiting their capability to produce regular mature blood elements thus, which can lead to low platelet counts. The results of the research were presented at this year’s 2009 American Culture of Hematology Annual Getting together with and Exposition . Interim Outcomes from Long-Term Open-Label Extension Research of Nplate in MDS The ongoing, open-label extension research was designed to measure the efficacy and basic safety of Nplate in lower risk MDS patients. The primary endpoints of the interim study for presentation at ASH evaluated adverse event rates with long-term use of Nplate and incidence of antibody advancement to Nplate and/or thrombopoietin .

online pharmacy

Amneal’s Esomeprazole Strontium 49.3 mg delayed-release capsules available for GERD patients now Amneal Pharmaceuticals LLC today announced the release of its branded Esomeprazole Strontium 49.3 mg delayed-launch capsules. Amneal can be marketing the 505 product in the usa under an exclusive license and distribution agreement with Hanmi Pharmaceutical Co. Ltd of South Korea. Each 49. Esomeprazole Strontium capsules can be found in 30-count bottles. Stated in the United Says, Esomeprazole Strontium begins shipping Wednesday, 18th through the three major U December.S.

Other entries from category "doctor":

Random entries